Search research articles
Contact Us
Filters
Showing results (1-10 of 47) with videos related to
Page
of 5
Sort By:
Current Opinion in Immunology
|
March 6, 2021
Resistance mechanisms to checkpoint inhibitors
Sarah A Weiss, Mario Sznol
Cancer Journal (Sudbury, Mass.)
|
March 25, 2020
Prognostic and Predictive Biomarkers in Oligometastatic Disease
Kevin J Barnum, Sarah A Weiss
Nature Immunology
|
August 26, 2018
Publisher Correction: Gene regulation: c-Maf in CD4<sup>+</sup> T cells: it's all about context
W Nicholas Haining, Sarah A Weiss
Frontiers in Oncology
|
September 12, 2025
Case Report: Recurrent supraglottitis in a patient with metastatic melanoma treated with ipilimumab and nivolumab
Marisa Palmeri, Sarah A Weiss, Phillip Purnell
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 30, 2019
Immunotherapy of Melanoma: Facts and Hopes
Sarah A Weiss, Jedd D Wolchok, Mario Sznol
Current Treatment Options in Oncology
|
May 3, 2014
Update on vaccines for high-risk melanoma
Sarah A Weiss, Sunandana Chandra, Anna C Pavlick
Cancer
|
August 27, 2015
Revisiting determinants of prognosis in cutaneous melanoma
Sarah A Weiss, Douglas Hanniford, Eva Hernando, et al.
Journal for Immunotherapy of Cancer
|
October 19, 2019
Seronegative autoimmune autonomic ganglionopathy from dual immune checkpoint inhibition in a patient with metastatic melanoma
Catherine A Gao, Urs M Weber, Aldo J Peixoto, et al.
Case Reports in Radiology
|
November 10, 2025
Metastatic Merkel Cell Carcinoma Incidentally Detected on PSMA PET/CT in a Patient With Metastatic Prostate Cancer
William Y Raynor, Manas Ranpariya, Jeffrey S Kempf, et al.
Frontiers in Transplantation
|
July 12, 2024
Use of immune checkpoint inhibitors in solid organ transplant recipients with advanced cutaneous malignancies
Stephanie Ji, Hao Liu, Laura Pachella, et al.
Page
of 5
Search research articles
Search
Showing results (1-10 of 47) with videos related to
Sort By:
Page
of 5
Current Opinion in Immunology
|
March 6, 2021
Resistance mechanisms to checkpoint inhibitors
Sarah A Weiss, Mario Sznol
Cancer Journal (Sudbury, Mass.)
|
March 25, 2020
Prognostic and Predictive Biomarkers in Oligometastatic Disease
Kevin J Barnum, Sarah A Weiss
Nature Immunology
|
August 26, 2018
Publisher Correction: Gene regulation: c-Maf in CD4<sup>+</sup> T cells: it's all about context
W Nicholas Haining, Sarah A Weiss
Frontiers in Oncology
|
September 12, 2025
Case Report: Recurrent supraglottitis in a patient with metastatic melanoma treated with ipilimumab and nivolumab
Marisa Palmeri, Sarah A Weiss, Phillip Purnell
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 30, 2019
Immunotherapy of Melanoma: Facts and Hopes
Sarah A Weiss, Jedd D Wolchok, Mario Sznol
Current Treatment Options in Oncology
|
May 3, 2014
Update on vaccines for high-risk melanoma
Sarah A Weiss, Sunandana Chandra, Anna C Pavlick
Cancer
|
August 27, 2015
Revisiting determinants of prognosis in cutaneous melanoma
Sarah A Weiss, Douglas Hanniford, Eva Hernando, et al.
Journal for Immunotherapy of Cancer
|
October 19, 2019
Seronegative autoimmune autonomic ganglionopathy from dual immune checkpoint inhibition in a patient with metastatic melanoma
Catherine A Gao, Urs M Weber, Aldo J Peixoto, et al.
Case Reports in Radiology
|
November 10, 2025
Metastatic Merkel Cell Carcinoma Incidentally Detected on PSMA PET/CT in a Patient With Metastatic Prostate Cancer
William Y Raynor, Manas Ranpariya, Jeffrey S Kempf, et al.
Frontiers in Transplantation
|
July 12, 2024
Use of immune checkpoint inhibitors in solid organ transplant recipients with advanced cutaneous malignancies
Stephanie Ji, Hao Liu, Laura Pachella, et al.
Page
of 5